Vanda Pharmaceuticals Inc (NASDAQ: VNDA) on Friday, soared 3.70% from the previous trading day, before settling in for the closing price of $4.74. Within the past 52 weeks, VNDA’s price has moved between $3.30 and $6.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.11%. The company achieved an average annual earnings per share of -1300.00%. With a float of $55.19 million, this company’s outstanding shares have now reached $57.53 million.
Let’s determine the extent of company efficiency that accounts for 203 employees. In terms of profitability, gross margin is 90.95%, operating margin of -17.84%, and the pretax margin is -6.57%.
Vanda Pharmaceuticals Inc (VNDA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vanda Pharmaceuticals Inc is 5.31%, while institutional ownership is 75.03%. The most recent insider transaction that took place on Jul 29 ’24, was worth 13,327. In this transaction SVP, CFO & Treasurer of this company sold 2,251 shares at a rate of $5.92, taking the stock ownership to the 228,763 shares. Before that another transaction happened on Jul 29 ’24, when Company’s Officer proposed sale 2,251 for $5.92, making the entire transaction worth $13,327.
Vanda Pharmaceuticals Inc (VNDA) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.03 earnings per share (EPS) for the period topping the consensus outlook (set at -0.13) by 0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1300.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 36.10% during the next five years compared to -37.98% drop over the previous five years of trading.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
Vanda Pharmaceuticals Inc (VNDA) is currently performing well based on its current performance indicators. A quick ratio of 4.67 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach 0.27 in one year’s time.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
Looking closely at Vanda Pharmaceuticals Inc (NASDAQ: VNDA), its last 5-days average volume was 1.63 million, which is a jump from its year-to-date volume of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 52.46%. Additionally, its Average True Range was 0.22.
During the past 100 days, Vanda Pharmaceuticals Inc’s (VNDA) raw stochastic average was set at 23.33%, which indicates a significant decrease from 58.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.62% in the past 14 days, which was lower than the 55.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.94, while its 200-day Moving Average is $4.84. However, in the short run, Vanda Pharmaceuticals Inc’s stock first resistance to watch stands at $5.00. Second resistance stands at $5.09. The third major resistance level sits at $5.26. If the price goes on to break the first support level at $4.75, it is likely to go to the next support level at $4.58. Should the price break the second support level, the third support level stands at $4.49.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Key Stats
Market capitalization of the company is 286.20 million based on 58,198K outstanding shares. Right now, sales total 192,640 K and income totals 2,510 K. The company made 50,470 K in profit during its latest quarter, and -4,520 K in sales during its previous quarter.
